Lab Manager: New Tech Created To Aid COVID-19 Vaccine Immunity Monitoring

As the COVID-19 vaccine becomes available to the public, immunity monitoring will play an important role in determining whether the vaccine is effective for an individual, and for how long. Benjamin Larimer, PhD, researcher at the University of Alabama at Birmingham (UAB), has developed a technology with potential use as an in-home antibody test.

Larimer’s diagnostic test is an accurate and reliable method for determining whether individuals are protected against COVID-19. The technology identifies neutralizing antibodies—those that block the virus from infecting cells. Emerging research suggests neutralizing antibodies offer the best protection against the virus.

View full article in Lab Manager.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a Birmingham Community partner.